Cargando…
Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
Background: Lung cancer is the number one cause of mortality among all types of cancer worldwide. Its treatment landscape has shifted from the classic chemotherapy alone to newer regimens based on the discovery of new immunotherapy and targeted therapy drugs. However, chemotherapy is still an option...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219655/ https://www.ncbi.nlm.nih.gov/pubmed/37235814 http://dx.doi.org/10.18632/oncotarget.28444 |